Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics, from a shareholder group led by European private equity .
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.